Loading clinical trials...
Showing 1-1 of 1 trials
NCT07133074
The overall goal of the RENEW-IN intervention is to assess the impact of a BL allergy delabeling intervention on antibiotic use and clinical outcomes in patients with a hematologic malignancy.